Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alessandro Tuzi
Impressive Response to Tyrosine Kinase Inhibitors in a Patient With Respiratory Failure for EGFR -Mutated Metastatic Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
P1.01-19 Efficacy of Tyrosine Kinase Inhibitors in EGFR Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastases
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Current Oncology
Oncology
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Current Oncology
Oncology
Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations
OncoTargets and Therapy
Oncology
Pharmacology
Tyrosine Kinase Inhibitors in Lung Cancer
Hematology/Oncology Clinics of North America
Oncology
Hematology
Hitting the Target: Measuring EGFR Response to Tyrosine Kinase Inhibitors
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
JCES 01.18 Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Sequential Treatment of Tyrosine Kinase Inhibitors and Chemotherapy for EGFR-mutated Non-Small Cell Lung Cancer: A Meta-Analysis of Phase III Trials
OncoTargets and Therapy
Oncology
Pharmacology